Mariano Barbacid, el brillante científico que abre esperanza contra el cáncer de páncreas
El nombre de Mariano Barbacid ha cobrado especial relevancia en los últimos días tras la publicación de un estudio que podría marcar un antes y un des...
TL;DR
- Mariano Barbacid's research on pancreatic cancer has gained significant attention.
- His team at CNIO has successfully eliminated pancreatic tumors in animal models using a combined triple therapy.
- This new therapy targets three points of the KRAS oncogene pathway, preventing drug resistance.
- The discovery, published in PNAS, offers renewed hope for a disease with a low survival rate.
- Barbacid is a highly influential figure in contemporary molecular oncology, having isolated the first human oncogene in 1982.
- He founded and directed the CNIO, establishing it as a world-leading research center.
- Barbacid emphasizes the importance of clear vocation and supports public healthcare and local research.
- Despite his achievements, he considers himself a researcher who competes for funding like any other.